Evidence map›Paper›PMID 25643024›Full record

Trial reportExperimental and clinical psychopharmacology2015

A comparison of delay discounting in adolescents and adults in treatment for cannabis use disorders.

Dustin C Lee, Catherine Stanger, Alan J Budney

Open access · hybridAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Experimental and clinical psychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Delay discounting of different outcomes: Review and theory.Journal of the experimental analysis of behavior · 2020
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Life after life: Recidivism among individuals formerly sentenced to mandatory juvenile life without parole.Journal of research on adolescence : the official journal of the Society for Research on Adolescence · 2025
    Article
  7. Delay discounting and symptoms of anxiety and depression in adolescents experiencing challenges with managing type 1 diabetes.Children's health care : journal of the Association for the Care of Children's Health · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dustin C LeeDepartment of Psychiatry, Geisel School of Medicine at Dartmouth.
Catherine StangerDepartment of Psychiatry, Geisel School of Medicine at Dartmouth.
Alan J BudneyDepartment of Psychiatry, Geisel School of Medicine at Dartmouth.
Dartmouth College · US

Funding

Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Behavioral Treatment of Adolescent Marijuana UseR01DA015186 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI BUDNEY, ALAN JEFFREY · 2002 to 2017
$7.7M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
Targeting tobacco cessation during treatment for cannabis use disordersR01DA032243 · NIDA · DARTMOUTH COLLEGE · PI BUDNEY, ALAN JEFFREY · 2012 to 2015
$1.7M
Development and Efficacy Test of Computerized Treatment for Marijuana DependenceR01DA023526 · NIDA · UNIV OF ARKANSAS FOR MED SCIS · PI BUDNEY, ALAN JEFFREY · 2007 to 2010
$1.6M
NIDA NIH HHS P30 DA029926NIDA NIH HHS R01 DA015186NIDA NIH HHS R01-DA015186NIDA NIH HHS R01 DA023526NIDA NIH HHS R01-DA023526NIDA NIH HHS R01 DA032243NIDA NIH HHS R01-DA032243NIDA NIH HHS T32 DA037202NIDA NIH HHS T32-DA037202
6 · The paper itself

Abstract

Delay discounting is associated with problematic substance use and poorer treatment outcomes in adolescents and adults with substance use disorders. Although some research has addressed delay discounting among individuals with cannabis use disorders (CUDs), results have been equivocal, and no study has examined whether discounting rates differ between adolescent and adult cannabis users. The aim of this study was to compare discounting rates between adolescents and adults in treatment for CUD to determine whether discounting at intake or changes in discounting across treatment differed between age groups. Participants were 165 adolescents and 104 adults enrolled in treatment for CUD. Participants completed a delay discounting task at intake and end of treatment for 2 commodities (money and cannabis) at 2 different magnitudes ($100 and $1,000). Repeated measures mixed models examined differences in discounting rates by commodity and magnitude across age groups at intake and changes in discounting across treatment. At intake, adolescents discounted money more than adults whereas adults showed greater discounting at $100 magnitude than $1,000. In addition, adults had greater decreases in discounting of cannabis over the course of treatment. Overall, adolescents appeared less sensitive to changes in magnitude of rewards, discounted money at higher rates, and showed less improvement in discounting over the course of treatment compared to adults. Comparing delay discounting in adolescents and adults with CUD can contribute to a better understanding of how development influences the effect of discounting on substance use to better inform treatment for substance use disorders.

Indexed as

Delay DiscountingAdolescentAdolescent BehaviorAdultAge FactorsChildFemaleHumansMaleMarijuana AbusePilot ProjectsTreatment OutcomeYoung Adult

Identifiers

PMID25643024
PMCPMC4388800
OpenAlexW2325081070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.